Newsroom
-
Tuesday, 10 November 2015
-
Monday, 17 August 2015
Ferring Pharmaceuticals begins Phase 2b/3 trial of selepressin for treatment of septic shock.
-
Friday, 03 July 2015
-
Wednesday, 22 April 2015
-
Thursday, 16 April 2015
Ferring and the Institut Pasteur collaborate in novel IBD drug development project
-
Tuesday, 07 April 2015
-
Monday, 23 March 2015
Ferring launches its first Corporate Social Responsibility (CSR) Review
-
Thursday, 05 February 2015
Ferring Canada introduces NOCDURNA®, a new treatment for Canadian adults suffering from nocturia
-
Tuesday, 27 January 2015